KPRX
Kiora Pharmaceuticals, Inc.
2.66
2 x 1.93
2 x 3.43
bid
ask
+
0.03
1.14%
2 @ 04:00 AM
2.66 +0.00 (0.00%)
| Ytd | 35.03% | |
| 1y | -6.99% |
2.66
day range
2.73
1.76
52 week range
3.29
| Open | 2.66 | Prev Close | 2.63 | Low | 2.66 | High | 2.73 | Mkt Cap | 11.79M |
| Vol | 9.09K | Avg Vol | 504.76K | EPS | -2.70 | P/E | N/A | Forward P/E | -1.48 |
| Beta | -0.29 | Short Ratio | 0.27 | Inst. Own | 48.34% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 2.55 | 200-d Avg | 2.32 | 1yr Est | 40.50 |
| Income Statement | |||
| Operating Expenses | 2.50M | ||
| Research and Development Expense | 2.12M | ||
| Selling, General and Administrative Expense | 1.61M | ||
| Operating Income | -2.50M | ||
| Net Income | -2.42M | ||
| Net Income Common Stock | -2.42M | ||
| Net Income Common Stock (USD) | -2.42M | ||
| Consolidated Income | -2.42M | ||
| Earnings per Basic Share | -0.58 | ||
| Earnings per Basic Share (USD) | -0.58 | ||
| Earnings per Diluted Share | -0.58 | ||
| Earning Before Interest & Taxes (EBIT) | -2.42M | ||
| Earning Before Interest & Taxes (USD) | -2.42M | ||
| Weighted Average Shares | 4.17M | ||
| Weighted Average Shares Diluted | 4.17M | ||
| Balance Sheet | |||
| Cash and Equivalents | 10.96M | ||
| Cash and Equivalents (USD) | 10.96M | ||
| Investments | 2.92M | ||
| Investments Current | 2.92M | ||
| Trade and Non-Trade Receivables | 1.54M | ||
| Current Assets | 18.68M | ||
| Property, Plant & Equipment Net | 388.30K | ||
| Total Assets | 21.23M | ||
| Debt Current | 178.22K | ||
| Total Debt | 373.59K | ||
| Current Liabilities | 2.80M | ||
| Debt Non-Current | 195.37K | ||
| Total Liabilities | 7.29M | ||
| Accumulated Retained Earnings (Deficit) | -156.64M | ||
| Accumulated Other Comprehensive Income | -228.80K | ||
| Shareholders Equity | 13.93M | ||
| Shareholders Equity (USD) | 13.93M | ||
| Assets Non-Current | 2.54M | ||
| Total Debt (USD) | 373.59K | ||
| Deferred Revenue | 1.25M | ||
| Goodwill and Intangible Assets | 2.06M | ||
| Liabilities Non-Current | 4.49M | ||
| Trade and Non-Trade Payables | 594.87K | ||
| Tax Assets | 1.91M | ||
| Tax Liabilities | 102.15K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 41.98K | ||
| Net Cash Flow from Financing | -842.00 | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 2.26M | ||
| Capital Expenditure | -5.02K | ||
| Net Cash Flow from Investing | 5.40M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 5.41M | ||
| Net Cash Flow from Operations | -3.16M | ||
| Effect of Exchange Rate Changes on Cash | 20.10K | ||
| Share Based Compensation | 209.51K | ||